Pfizer

PFE58

S&P500

$24.80arrow_drop_down4.68%-$1.21

S&P500

PFE58

$24.80

arrow_drop_down4.68%-$1.21

S&P500

Performance History

Key Stats
Open	$25.70
Prev. Close	$26.02
EPS	0.71

Next Earnings Date	Mar 3, 2025

	LOW	HIGH
Day Range	24.51	26.02
52 Week Range	24.51	33.92

Ratios







EPS	0.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Pfizer (PFE)

Pfizer Inc., incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing healthcare products. The Company's segments include Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its EH segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. The Company's IH segment focuses on developing and commercializing medicines and vaccines. The Company also provides contract manufacturing services. The Company develops and produces medicines and vaccines for a range of conditions, including immune and inflammatory diseases, cardiovascular and metabolic diseases, oncology, rare diseases and neuroscience. Its products include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Pfizer's stock price history has been relatively stable over the years, with some fluctuations in response to market conditions and company news. The stock has generally shown a consistent growth trend, reflecting the company's strong financial performance and successful drug development pipeline. As of [current date], Pfizer's stock price is [stock price].

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO: Dr. Albert Bourla D.V.M., DVM, Ph.D.
Headquarters: New York
Employees: 83000
Exchange: NYSE

Keep an eye on Pfizer

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Pfizer 's (PFE) price per share?

The current price per share for Pfizer (PFE) is $24.8. The stock has seen a price change of -$1.22 recently, indicating a -4.69% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Pfizer (PFE)?

For Pfizer (PFE), the 52-week high is $33.92, which is 36.77% from the current price. The 52-week low is $24.51, the current price is 1.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Pfizer (PFE) a growth stock?

Pfizer (PFE) has shown an average price growth of -6.65% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pfizer as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Pfizer (PFE) stock price performance year to date (YTD)?

As of the latest data, Pfizer (PFE) has a year-to-date price change of -16.58%. Over the past month, the stock has experienced a price change of -16.41%. Over the last three months, the change has been -12.37%. Over the past six months, the figure is -14.25%. Looking at a longer horizon, the five-year price change stands at -33.37%.

help

Is Pfizer (PFE) a profitable company?

Pfizer (PFE) has a net income of $2.13B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 49.25% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 32.99% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $58.5B, although specific revenue growth data is currently not available. The gross profit is $28.81B. Operating income is noted at $3.36B. Furthermore, the EBITDA is $19.4B.

help

What is the market capitalization of Pfizer (PFE)?

Pfizer (PFE) has a market capitalization of $140.54B. The average daily trading volume is 24.89, indicating the stock's liquidity and investor engagement.